Titre : How Do Direct-Acting Antivirals for HCV Affect HCC Risk?
link : How Do Direct-Acting Antivirals for HCV Affect HCC Risk?
How Do Direct-Acting Antivirals for HCV Affect HCC Risk?
COMMENTARY
How Do Direct-Acting Antivirals for Hepatitis C Affect the Risk for Hepatocellular Carcinoma?
Sheila L. Eswaran, MD, MS; Nancy Reau, MD
How Do Direct-Acting Antivirals for Hepatitis C Affect the Risk for Hepatocellular Carcinoma?
Sheila L. Eswaran, MD, MS; Nancy Reau, MD
August 15, 2017
Hepatocellular carcinoma (HCC), which has an annual incidence rate of 1%-4%,[1] is a potential complication of hepatitis C virus (HCV) cirrhosis owing to a multistep carcinogenesis pathway. Previous HCV treatment with interferon was associated with poor cure rates and was limited to individuals with early fibrosis or well-compensated cirrhosis. Such therapy, however, also led to a decrease in HCC after a sustained viral response (SVR).[2,3] Although remarkable progress has occurred in curing HCV in the current direct-acting antiviral (DAA) era, there is controversy regarding the associated risk of patients developing either incident (new, de novo) or recurrent HCC after DAA treatment. Additional data also suggest a lower SVR rate in patients with HCC.
Thus articles How Do Direct-Acting Antivirals for HCV Affect HCC Risk?
that is all articles How Do Direct-Acting Antivirals for HCV Affect HCC Risk? This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article How Do Direct-Acting Antivirals for HCV Affect HCC Risk? the link address https://newsaninpiration.blogspot.com/2017/08/how-do-direct-acting-antivirals-for-hcv.html
0 Response to "How Do Direct-Acting Antivirals for HCV Affect HCC Risk?"
Post a Comment